06.17.25 -- How To Automate Bioprocesses Without Locking Out Future Upgrades

Learn more about two unique methods for clinical-scale expansion of gamma delta T cells, which are well suited for a wide variety of treatments due to their reduced risk of graft-versus-host disease.

Explore advanced magnetic bead-based methods for isolating T cells, enabling high efficiency, scalability, and viability in CAR T cell manufacturing while addressing challenges posed by diverse patient samples.

Multi-well inserts allowing for a two-chamber system that can expose cell cultures from above and below provide greater versatility and expand research options compared to standard cell culture plates.

Unlock insights into sterile gas filtration challenges in bioprocessing. Watch this on-demand session to learn optimization strategies for critical applications and improved filter performance.

A crucial consideration for researchers is off-target editing – unintended DNA modifications at sites other than the intended target. Explore the complexities and strategies to mitigate these effects.

An innovative transfection system addresses common production challenges by offering higher AAV titers, improved percent-full AAV capsids, and a straightforward workflow for AAV production platforms.

Explore data-driven advancements in cell therapy manufacturing and learn how focusing on biology first can lead to more robust and scalable manufacturing solutions.

Optimize your mRNA production by identifying an optimum set of conditions for the IVT reaction that produces high-quality mRNA in high yield using a design of experiment (DoE) approach.

Reduce the time and risks involved in maintaining a traditional bioreactor with this single-use solution for biopharmaceutical manufacturers.

For many applications, cutting-edge centrifugation technologies can achieve cell harvest optimization, providing a low-shear, high-yield process that is tightly controlled and highly reproducible.

Cleanroom systems are purposely designed to simplify the implementation of the aseptic manufacturing space that the industry needs to meet future sterile injectable capacity demand.